Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders

GeroScience(2024)10.1007/s11357-024-01120-4Source: DataRank Database

Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders is a research paper published in GeroScience (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 2.45)OA: hybridTopics (57)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Kelli L. Vaughan ORCID,Yun Wang ORCID,Seong‐Jin Yu ORCID,Eun-Kyung Bae ORCID,Ian A. Tamargo

Live enrichment

PubMed:38532069 PMC:PMC11335710 OpenAlex:https://openalex.org/W4393247075

Michael J. Fox Foundation for Parkinson's Research

Grant: NHG

National Institute on Aging

Grant: Intramural Research Program AG000333

National Institute on Aging

Grant: P30AG072976

National Institute on Aging

Grant: R56AG072810

National Institute on Aging

Grant: R21AG074539

National Institute on Aging

Grant: 2R56AG051086

National Health Research Institutes, Taiwan

Grant: Intramural Research Grant

Ministry of Science and Technology, Taiwan

Grant: MOST-110-2320-B-400-007

Ministry of Science and Technology, Taiwan

Grant: MOST-111-2320-B-400-010

NIA NIH HHS

Grant: R56 AG051086

National Institutes of Health

Grant: 1ZIAAG000333-15

Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)

National Institutes of Health

Grant: 1R21AG074539-01A1

Alzheimer's disease-linked microRNA Exploration of UTR Polymorphisms (AdmiRE-UP)

National Institutes of Health

Grant: 1R56AG072810-01

Role of microRNA in regulating Fe, Amyloid, and Tau (FeAT) in Alzheimer's disease

National Institutes of Health

Grant: 2R56AG051086-06A1

Neurobiological Role of MicroRNA in Alzheimer's

National Institutes of Health

Grant: 5P30AG072976-02

Indiana Alzheimer's Disease Research Center

FWCI

2.45

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s11357-024-01120-4.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11357-024-01120-4.pdf

publisherhttps://link.springer.com/article/10.1007/s11357-024-01120-4/fulltext.html

journalhttps://doi.org/10.1007/s11357-024-01120-4

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38532069

Fields of Study

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchPharmacological Effects and Toxicity Studies0301 basic medicine0303 health sciences03 medical and health sciencesSitagliptin PhosphateAnimalsIncretinsAdministration, OralGlucagon-Like Peptide 1Neurodegenerative DiseasesMaleDipeptidyl-Peptidase IV InhibitorsGastric Inhibitory PolypeptideHumansMacaca fascicularisDose-Response Relationship, Drug

MeSH Terms

Sitagliptin PhosphateAdministration, OralAnimalsDose-Response Relationship, DrugGastric Inhibitory PolypeptideHumansMacaca fascicularisMaleNeurodegenerative DiseasesGlucagon-Like Peptide 1IncretinsDipeptidyl-Peptidase IV Inhibitors

Keywords

SitagliptinIncretinMedicineInternal medicineEndocrinologyDiabetes mellitusSitagliptin PhosphatePharmacologyType 2 diabetesGlucagon-like peptide-1 (GLP-1)Parkinson’s DiseaseNonhuman PrimateGlucose-dependent Insulinotropic Polypeptide (Gip)Dipeptidyl Peptidase 4 (Dpp-4)MaleDipeptidyl-Peptidase IV InhibitorsDose-Response Relationship, Drug610Administration, OralNeurodegenerative DiseasesGastric Inhibitory PolypeptideIncretinsMacaca fascicularisGlucagon-Like Peptide 1AnimalsHumansOriginal Article

Sustainable Development Goals

SDG 0: Good health and well-being